Skip to main content
OpenTrials

Clinical trial condition

Neurocutaneous Syndromes

Explore clinical trials studying Neurocutaneous Syndromes. Study availability and eligibility vary by location and protocol.

346 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Neurocutaneous Syndromes trial results

Completed

Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults

NCT02101736

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Selumetinib Paediatric NF1 Japan Study

NCT04495127

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Minatoku, Japan
  • Research Site Nagoya, Japan
  • Research Site Setagaya-ku, Japan
View Trial Details
Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

NCT04285346

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more
Locations
  • Marinus Research Site Los Angeles, California, United States
  • Marinus Research Site Palo Alto, California, United States
  • Marinus Research Site Boston, Massachusetts, United States
  • Marinus Research Site Livingston, New Jersey, United States
View Trial Details
Completed

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

NCT02544763

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
Locations
  • UAB Epilepsy Center Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCLA-Pediatric Neurology Los Angeles, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
View all 44 locations
View Trial Details
Completed

Frameshift Peptides of Children With NF1

NCT04212351

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
  • The University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

NCT04435665

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +14 more
Locations
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Minnesota Clinical Study Center New Brighton, Minnesota, United States
  • Skin Search of Rochester, Inc. Rochester, New York, United States
  • DermResearch Austin, Texas, United States
View Trial Details

Related conditions